AKAN CIK: 1888014

Akanda Corp.

  • Canada
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
3.98
FY22:
3.82
FY23:
1.81
FY24:
5.06
FY25:
3.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.07
FY22:
35.2
FY23:
7.03
FY24:
2.86
FY25:
2.59
Total assets
Change from FY21 to FY25
millions USD
FY21:
8.05
FY22:
39.0
FY23:
8.84
FY24:
7.91
FY25:
6.20

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
8.27
FY22:
9.35
FY23:
10.2
FY24:
3.64
FY25:
6.20
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.98
FY22:
2.75
FY23:
2.50
FY24:
0
FY25:
12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.20
FY22:
26.9
FY23:
−3.83
FY24:
4.28
FY25:
−12.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
8.05
FY22:
39.0
FY23:
8.84
FY24:
7.91
FY25:
6.20

All amounts in millions USD Data sources:SEC EDGARTwelve Data